InspireMD Inc - Asset Resilience Ratio
InspireMD Inc (NSPR) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of InspireMD Inc for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2024)
This chart shows how InspireMD Inc's Asset Resilience Ratio has changed over time. See NSPR book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down InspireMD Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see NSPR market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: InspireMD Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
InspireMD Inc Industry Peers by Asset Resilience Ratio
Compare InspireMD Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for InspireMD Inc (2011–2024)
The table below shows the annual Asset Resilience Ratio data for InspireMD Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 33.59% | $15.72 Million | $46.81 Million | -28.09pp |
| 2023-12-31 | 61.67% | $29.38 Million | $47.64 Million | +8.25pp |
| 2022-12-31 | 53.43% | $13.17 Million | $24.65 Million | -2.06pp |
| 2021-12-31 | 55.49% | $22.04 Million | $39.71 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $17.78 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $6.11 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $9.41 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $5.78 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $11.46 Million | -- |
| 2012-12-31 | 0.58% | $93.00K | $16.01 Million | +0.35pp |
| 2012-06-30 | 0.23% | $37.00K | $16.01 Million | -0.34pp |
| 2011-12-31 | 0.57% | $91.00K | $16.01 Million | -- |
About InspireMD Inc
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding car… Read more